NPJ breast cancer
Journal
Overview
publication venue for
-
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique..
10.
2024
-
Incidence of HER2-expressing brain metastases in patients with HER2-null breast cancer: a matched case analysis..
9.
2023
-
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy..
9.
2023
-
Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors..
9.
2023
-
Real-world study of overall survival with palbociclib plus aromatase inhibitor in HR+/HER2- metastatic breast cancer..
8.
2022
-
ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin..
8.
2022
-
ERĪ±-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance..
8.
2022
-
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer..
8.
2022
-
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation..
8.
2022
-
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases..
8.
2022
-
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab..
8.
2022
-
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial..
8.
2022
-
Increased trunk fat is associated with altered gene expression in breast tissue of normal weight women..
8.
2022
-
Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program..
8.
2022
-
Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC..
8.
2022
-
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer..
8.
2022
-
Acupuncture versus cognitive behavioral therapy for pain among cancer survivors with insomnia: an exploratory analysis of a randomized clinical trial..
7.
2021
-
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies..
7.
2021
-
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer..
7.
2021
-
Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry..
7.
2021
-
Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer..
7.
2021
-
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial..
7.
2021
-
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancer..
7.
2021
-
Automated percent mammographic density, mammographic texture variation, and risk of breast cancer: a nested case-control study..
7.
2021
-
Anti-tumor effects of an ID antagonist with no observed acquired resistance..
7.
2021
-
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer..
7.
2021
-
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer..
7.
2021
-
The impact of mammographic screening on the subsequent breast cancer risk associated with biopsy-proven benign breast disease..
7.
2021
-
Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations..
7.
2021
-
A randomized intervention involving family to improve communication in breast cancer care..
7.
2021
-
S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue..
6.
2020
-
Adolescent alcohol, nuts, and fiber: combined effects on benign breast disease risk in young women..
6.
2020
-
The genomic landscape of metastatic histologic special types of invasive breast cancer..
6.
2020
-
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer..
6.
2020
-
PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer..
5.
2019
-
Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification..
5.
2019
-
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer..
5.
2019
-
AKT1low quiescent cancer cells in ductal carcinoma in situ of the breast..
5.
2019
-
Androgen receptor expression in normal breast tissue and subsequent breast cancer risk..
4.
2018
-
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast..
3.
2017
-
Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue..
3.
2017
-
Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial..
2.
2016
-
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor..
2.
2016
-
Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer..
2.
2016
-
TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients..
2.
2016
-
Decreased gastrointestinal toxicity associated with a novel capecitabine schedule (7 days on and 7 days off): a systematic review..
2.
2016
-
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)..
2.
2016
-
Cell-to-cell communication in cancer: workshop report..
1.
2015
-
Spatiotemporal progression of metastatic breast cancer: a Markov chain model highlighting the role of early metastatic sites..
1.
2015
-
Breast cancer survivors are at an increased risk for osteoporotic fractures not explained by lower BMD: a retrospective analysis..
1.
2015
-
Somatic mutations in leukocytes infiltrating primary breast cancers..
1.
2015
-
Supporting data sharing..
5.
2019
-
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
2020
-
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
2020
-
Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer.
2024
-
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
2021
-
A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases.
2021
-
Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design.
2017
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)